2017
DOI: 10.1017/s0950268817002266
|View full text |Cite
|
Sign up to set email alerts
|

Different Escherichia coli B2-ST131 clades (B and C) producing extended-spectrum β-lactamases (ESBL) colonizing residents of Portuguese nursing homes

Abstract: ESBL-producing Enterobacteriaceae and particularly Escherichia coli ST131 isolates producing CTX-M enzymes are commonly found colonizing the intestine of nursing home (NH) residents, but ST131 subclonal structure has been scarcely explored in this vulnerable population. Our goal was to perform a pilot study to assess the faecal carriage rate and epidemiological features of ESBL- and/or carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE, respectively) among NH residents. For this purpose, faecal samples… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 13 publications
1
10
0
Order By: Relevance
“…coli belonging to the ST131 pandemic high-risk clone has been identified in human, animal, environmental, and food samples (Figure 1). In addition, E. coli ST131 has been frequently reported carrying clinically significant antimicrobial resistance genes, such as mcr-types and/or ESBL genes (Rodrigues et al, 2017;Reid et al, 2019), and associated with extraintestinal diseases, mainly bloodstream and urinary tract infections (Liu et al, 2018;Mamani et al, 2019;Reid et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…coli belonging to the ST131 pandemic high-risk clone has been identified in human, animal, environmental, and food samples (Figure 1). In addition, E. coli ST131 has been frequently reported carrying clinically significant antimicrobial resistance genes, such as mcr-types and/or ESBL genes (Rodrigues et al, 2017;Reid et al, 2019), and associated with extraintestinal diseases, mainly bloodstream and urinary tract infections (Liu et al, 2018;Mamani et al, 2019;Reid et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, we had a balanced number of publications on both groups, for each MDRO (Table 2). The ESBL Enterobacterales prevalence increased from 10.5% [14,18,22,23,25,31,33,39,57,75,76,82,85,89,99,101,102,104,106,107,111,112,116,119,[121][122][123][124][125]143] to 15.1% [1,16,[19][20][21]34,62,73,83,97,100,103,105,[108][109][110][113][114][115]117,…”
Section: Changes In Mdro Prevalence Over Timementioning
confidence: 99%
“…Asia reported the highest prevalence of ESBL Enterobacterales [100,111,112], CR Enterobacterales [60,67,100,132] and MRSA [26,28,35,54,60,67,69,87,95,96]. In contrast, the lowest prevalence of ESBL Enterobacterales, CR Enterobacterales and MRSA have been reported in Oceania [82,106,113,125], Europe [1,13,[18][19][20][21][22]34,83,103,104,[108][109][110]118] and South America [61]. With respect to MDR P. aeruginosa [64,142], A. baumannii [64,74,141], VRE [14,23,33,38,58,59,[64]…”
Section: Mdro Prevalencementioning
confidence: 99%
“…Particularly, the CTX-M-15 is frequently found among Enterobacteriaceae in humans in Europe [ 17 , 18 ], specifically in both clinical samples and healthy humans in Portugal [ 19 , 20 , 21 ]. Moreover, the CTX-M-15 β-lactamase is frequently associated with the uropathogenic international E. coli clone ST131 [ 22 , 23 ]. In the last decade, E. coli clonal group ST131 has emerged as a high-risk clone with important clinical health concerns causing multidrug-resistant (MDR) infections worldwide [ 11 ].…”
Section: Introductionmentioning
confidence: 99%